130 related articles for article (PubMed ID: 11311792)
1. Pallidal border cells: an anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
Bezard E; Boraud T; Chalon S; Brotchie JM; Guilloteau D; Gross CE
Neuroscience; 2001; 103(1):117-23. PubMed ID: 11311792
[TBL] [Abstract][Full Text] [Related]
2. Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
Schneider JS; Dacko S
Brain Res; 1991 Aug; 556(2):292-6. PubMed ID: 1682010
[TBL] [Abstract][Full Text] [Related]
3. Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
Boraud T; Bezard E; Stutzmann JM; Bioulac B; Gross CE
Neurosci Lett; 2000 Mar; 281(2-3):75-8. PubMed ID: 10704746
[TBL] [Abstract][Full Text] [Related]
4. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
Heimer G; Bar-Gad I; Goldberg JA; Bergman H
J Neurosci; 2002 Sep; 22(18):7850-5. PubMed ID: 12223537
[TBL] [Abstract][Full Text] [Related]
5. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism.
Filion M; Tremblay L; Bédard PJ
Brain Res; 1991 Apr; 547(1):152-61. PubMed ID: 1677608
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
Jan C; François C; Tandé D; Yelnik J; Tremblay L; Agid Y; Hirsch E
Eur J Neurosci; 2000 Dec; 12(12):4525-35. PubMed ID: 11122363
[TBL] [Abstract][Full Text] [Related]
7. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism.
Nini A; Feingold A; Slovin H; Bergman H
J Neurophysiol; 1995 Oct; 74(4):1800-5. PubMed ID: 8989416
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment.
He L; Di Monte DA; Langston JW; Quik M
Neuroscience; 2000; 99(4):697-704. PubMed ID: 10974432
[TBL] [Abstract][Full Text] [Related]
9. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
Boraud T; Bezard E; Bioulac B; Gross CE
Brain; 2001 Mar; 124(Pt 3):546-57. PubMed ID: 11222455
[TBL] [Abstract][Full Text] [Related]
10. MPTP-Induced pallidal lesions in rhesus monkeys.
Zhang Z; Zhang M; Ai Y; Avison C; Gash DM
Exp Neurol; 1999 Jan; 155(1):140-9. PubMed ID: 9918713
[TBL] [Abstract][Full Text] [Related]
11. Physiological studies of information processing in the normal and Parkinsonian basal ganglia: pallidal activity in Go/No-Go task and following MPTP treatment.
Morris G; Hershkovitz Y; Raz A; Nevet A; Bergman H
Prog Brain Res; 2005; 147():285-93. PubMed ID: 15581713
[TBL] [Abstract][Full Text] [Related]
12. Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.
Quik M; Polonskaya Y; Kulak JM; McIntosh JM
J Neurosci; 2001 Aug; 21(15):5494-500. PubMed ID: 11466420
[TBL] [Abstract][Full Text] [Related]
13. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
[TBL] [Abstract][Full Text] [Related]
14. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
Page RD; Sambrook MA; Crossman AR
Neuroscience; 1993 Jul; 55(1):147-65. PubMed ID: 7688878
[TBL] [Abstract][Full Text] [Related]
15. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
[TBL] [Abstract][Full Text] [Related]
16. Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia.
Tachibana Y; Iwamuro H; Kita H; Takada M; Nambu A
Eur J Neurosci; 2011 Nov; 34(9):1470-84. PubMed ID: 22034978
[TBL] [Abstract][Full Text] [Related]
17. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Rioux L; Frohna PA; Joyce JN; Schneider JS
Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
[TBL] [Abstract][Full Text] [Related]
18. Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment.
Quik M; Police S; He L; Di Monte DA; Langston JW
Neuroscience; 2000; 98(2):263-73. PubMed ID: 10854757
[TBL] [Abstract][Full Text] [Related]
19. Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism.
Heimer G; Rivlin-Etzion M; Bar-Gad I; Goldberg JA; Haber SN; Bergman H
J Neurosci; 2006 Aug; 26(31):8101-14. PubMed ID: 16885224
[TBL] [Abstract][Full Text] [Related]
20. The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.
Speciale SG; Liang CL; Sonsalla PK; Edwards RH; German DC
Neuroscience; 1998 Jun; 84(4):1177-85. PubMed ID: 9578404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
